Teladoc Health, Inc. (NYSE:TDOC) Receives $9.60 Average Price Target from Brokerages

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been assigned an average rating of "Hold" from the nineteen brokerages that are presently covering the stock, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $9.60.

TDOC has been the subject of a number of recent research reports. Canaccord Genuity Group decreased their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Citigroup reduced their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Jefferies Financial Group lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Finally, The Goldman Sachs Group dropped their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the transaction, the insider now directly owns 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 29,667 shares of company stock valued at $220,901 over the last three months. 0.58% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently added to or reduced their stakes in TDOC. Robeco Institutional Asset Management B.V. increased its holdings in shares of Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after buying an additional 125,111 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Teladoc Health by 18.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after buying an additional 22,664 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in shares of Teladoc Health by 35.7% during the fourth quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock valued at $1,032,000 after buying an additional 29,903 shares during the period. Finally, Xponance Inc. raised its holdings in shares of Teladoc Health by 23.8% during the fourth quarter. Xponance Inc. now owns 13,861 shares of the health services provider's stock valued at $126,000 after acquiring an additional 2,661 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Stock Up 2.2%

Shares of TDOC traded up $0.15 during trading hours on Friday, reaching $7.21. The stock had a trading volume of 597,970 shares, compared to its average volume of 6,236,794. The firm has a 50-day simple moving average of $7.20 and a 200 day simple moving average of $9.17. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of -1.24 and a beta of 1.82.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.